ABUS
#2545
Arbutus Biopharma Corporation - Common Stock
4.5 0 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.39%
Monthly Change
+3.45%
6 month change
+14.21%
Year Change
+43.77%
Previous Close
4.6 1
Open
4.4 9
Low
4.4 9
High
4.5 2
Volume
168
Financials
- Market Capitalization 888.92 M
- Employee 19
- Founded 2007
- CEO William H. Collier
- Website www.arbutusbio.com
- Headquarter British Columbia, Canada
- FIGI BBG000RR8V85
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
5.42
Price to sales ratio
4.58
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2533 |  DBVT DBV Technologies S.A. - American Depositary Shares | 15.66 USD | -1.63% | -5.43% | -14.47% | +61.78% | 927.20 M USD | ||
| 2541 |  LBRX LB Pharmaceuticals Inc - Common Stock | 32.17 USD | +0.47% | -8.06% | +11.93% | +69.32% | 922.53 M USD | ||
| 2555 |  GERN Geron Corporation - Common Stock | 1.42 USD | +2.90% | -8.39% | +23.48% | +10.94% | 910.96 M USD | ||
| 2567 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 16.96 USD | +0.24% | -0.24% | +3.29% | +18.19% | 874.34 M USD |
Frequently asked questions about Arbutus Biopharma Corporation - Common Stock
What is the Arbutus Biopharma Corporation - Common Stock stock price today?
The current price of Arbutus Biopharma Corporation - Common Stock (ABUS) is 4.5. Over the past 24 hours, the stock has changed by -2.39%. Follow the ABUS chart for real-time price dynamics.
What is the stock ticker of Arbutus Biopharma Corporation - Common Stock?
Arbutus Biopharma Corporation - Common Stock trades under the ticker ABUS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Arbutus Biopharma Corporation - Common Stock stock going up?
ABUS has changed by -13.63% over the last week, +3.45% over the last month, and +43.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Arbutus Biopharma Corporation - Common Stock net income for the last quarter?
Arbutus Biopharma Corporation - Common Stock reported net income of 169.69 M for the last quarter. The previous quarter showed -3.76 M, which means net income changed by +4617.97%.
How many employees does Arbutus Biopharma Corporation - Common Stock have?
As of the latest available data, Arbutus Biopharma Corporation - Common Stock has 19 employees. Workforce size can provide additional context about the company's scale and operations.
What is Arbutus Biopharma Corporation - Common Stock EBITDA?
Arbutus Biopharma Corporation - Common Stock EBITDA is 168.92 M, and its EBITDA margin is 94.3%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Arbutus Biopharma Corporation - Common Stock stock?
You can buy Arbutus Biopharma Corporation - Common Stock (ABUS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Arbutus Biopharma Corporation - Common Stock stock?
Investing in Arbutus Biopharma Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ABUS chart and related analysis on metatrader.com as part of your research.